Antibody Current Events | Antibody News | 6
|
| Page
6 of
13 |
256 Results |
|
|
|
Sort By:
Page Views | Date |
Which is more accurate, serology test or C14-urea breath test?
Serology and C14-UBT are the most commonly used non-invasive tests of H. pylori infection. The diagnostic characteristics of the tests depend also on the prevalence of H. pylori infection in the population tested. view more (2008-09-10)
A natural approach for HIV vaccine
For 25 years, researchers have tried and failed to develop an HIV vaccine, primarily by focusing on a small number of engineered "super antibodies" to fend off the virus before it takes hold. view more (2009-03-16)
First use of antibody and stem cell transplantation to successfully treat advanced leukemia
For the first time, researchers at Fred Hutchinson Cancer Research Center have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a group of leukemia and pre-leukemia patients for whom there previously had been no other curative treatment options. view more (2009-11-06)
Scientists Learn the Origin of Rogue B Cells
Doctors have long wondered why, in some people, the immune system turns against parts of the body it is designed to protect, leading to autoimmune disease. view more (2007-02-08)
Horse antibodies against the bird flu virus H5N1 are effective as treatment in mice
Antibodies against the bird flu virus H5N1, derived from horses, prevent mice infected with H5N1 from dying from the virus. view more (2006-03-28)
HIV uses several strategies to escape immune pressure
A study of how HIV mutates in response to immune system pressure by Emory Vaccine Center researchers shows that the virus can take several escape routes, not one preferred route. view more (2009-09-21)
What is the influence of tumor removal on the serum level of carbohydrate's antibody?
Cancer immune surveillance is considered to be important in the anti-tumor protection of the host. The growing tumor escapes the immune control under the immunosuppressive conditions. view more (2008-10-08)
UNH Glycomics Center Helps Identify Sugar Linkage That Could Lead To Better Treatment For Autoimmune Diseases
Researchers at the University of New Hampshire Glycomics Center have helped identify a specific carbohydrate structure that confers anti-inflammatory activity to a glycoprotein antibody that could lead to improved treatment of autoimmune diseases like lupus or rheumatoid arthritis. view more (2008-05-14)
MU researcher links hormone replacement therapy to breast cancer
Millions of post-menopausal women use hormone replacement therapy (HRT) as a method to reduce symptoms associated with menopause. In a recent University of Missouri study, researchers found that one of the hormones used in HRT, a synthetic progestin, could be a major factor in promoting breast cancer. view more (2008-04-02)
Simpler and quicker toxin detection
Several naturally occurring moulds that can grow in and on fruits such as apples, pears and grapes produce the toxic chemical Patulin, which has been shown to cause adverse effects in animals. Now scientists, collaborating with industrial partners, have developed a rapid test for Patulin, something that has eluded the fruit industry for 20 years,... view more... (2005-04-07)
Plants make vaccine for treating type of cancer in Stanford study
Plants could act as safe, speedy factories for growing antibodies for personalized treatments against a common form of cancer, according to new findings from the Stanford University School of Medicine. The findings came in the first human tests of an injectable vaccine grown in genetically engineered plants. view more (2008-07-22)
West Nile virus' spread through nerve cells linked to serious complication
Scientists believe they have found an explanation for a puzzling and serious complication of West Nile virus infection. view more (2007-10-19)
Adding epratuzumab to standard therapy
Adding a second monoclonal antibody drug to chemotherapy looks promising for treatment of diffuse large B-cell lymphoma. view more (2008-05-16)
Location matters, even for genes
Moving an active gene from the interior of the nucleus to its periphery can inactivate that gene report scientists from the University of Chicago Medical Center in an article to be published early online Feb.13, 2008, in the journal Nature. view more (2008-02-14)
Scripps research scientists devise approach that stops HIV at earliest stage of infection
Researchers at The Scripps Research Institute have developed a new two-punch strategy against HIV and they have already successfully tested aspects of it in the laboratory. view more (2008-02-28)
USU scientists report major advance in human antibody therapy against deadly Nipah virus
A collaborative research team from the Uniformed Services University of the Health Sciences (USU), Australian Animal Health Laboratory and National Cancer Institute, a component of the National Institutes of Health, reports a major step forward in the development of an effective therapy against two deadly viruses, Nipah virus and the related... view more... (2009-11-02)
Evolution in action: Our antibodies take 'evolutionary leaps' to fight microbes
With cold and flu season in full swing, the fact that viruses and bacteria rapidly evolve is apparent with every sneeze, sniffle, and cough. A new report in the January 2009 issue of The FASEB Journal, explains for the first time how humans keep up with microbes by rearranging the genes that make antibodies to foreign invaders. This research fills... view more... (2009-01-06)
Tattooing improves response to DNA vaccine
A tattoo can be more than just a fashion statement - it has potential medical value, according to an article published in the online open access journal, Genetic Vaccines and Therapy. view more (2008-02-07)
Toronto researcher's discovery points to a new treatment avenue for acute myeloid leukemia
Dr. John Dick, Senior Scientist at the Ontario Cancer Institute, the research arm of Princess Margaret Hospital, co-led a multinational team that has developed the first leukemia therapy that targets a protein, CD123, on the surface of cancer stem cells that drive acute myeloid leukemia (AML), which is an aggressive disease with a poor outcome. view more (2009-07-07)
Protein complementarity may offer new insights into autoimmune diseases
The discovery of "complementary" antibodies against plasminogen in patients with blood vessel inflammation caused by anti-neutrophil cytoplasmic autoantibodies (ANCAs) may lead to new approaches to research, testing, and treatment of ANCA vasculitis and other autoimmune diseases, suggests a paper in the December Journal of the American... view more... (2008-08-14)
|
|
| Page
6 of
13 |
256 Results |
|
|
|
Sort By:
Page Views | Date |
|
